UBS Maintains Neutral on Carter's, Raises Price Target to $41

UBS analyst Jay Sole maintains Carter's (NYSE:CRI) with a Neutral and raises the price target from $40 to $41.

Earnings Scheduled For May 6, 2026

Carter's Reports Q1 2026 Results: Full Earnings Call Transcript

Carter's Sees Q2 Adj EPS $0.02-$0.06 vs $(0.20) Est

Carter's (NYSE:CRI) is looking for Q2 Adj EPS of $0.02-$0.06 vs $(0.20) analyst estimate..

Carter's Q1 Adj. EPS $0.39 Beats $0.13 Estimate, Sales $681.113M Beat $660.582M Estimate

Carter's (NYSE:CRI) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.13 by 200 percent. This is a 40.91 percent decrease over earnings of $0.66 per share from the same period

Carter's Reiterates Q1, FY26 Guidance

Carter's, Inc. ("Carter's" or the "Company") (NYSE:CRI) reaffirmed its first quarter and full-year fiscal 2026 outlook that was provided on February 27, 2026. As announced this week, Carter's will report its results for

Carter's Appoints Sharon Price John President, CEO, Effective June 15

Carter's, Inc. ("Carter's" or the "Company") (NYSE:CRI), North America's largest and most-enduring apparel company exclusively for babies and young children, today announced the appointment of Sharon Price John as Chief

Wells Fargo Maintains Underweight on Carter's, Raises Price Target to $33

Wells Fargo analyst Ike Boruchow maintains Carter's (NYSE:CRI) with a Underweight and raises the price target from $28 to $33.